These results might explain the different effects of both RGD cadherins in the context of cancer cells: whereas CDH17 promotes cell adhesion and proliferation, VE-cadherin increases cell migration and invasion in addition to adhesion and proliferation [20,31]. Here, CDH17 is linked to cancer.